Materials Today Bio·24 SepNeuroimaging of indoleamine 2,3-dioxygenase 1 (Ido1) in Alzheimer's disease: Development of a novel ¹⁸F-labeled PET tracerExperiments in animalsBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunDiabetes Remission in Drug-Naïve Patients with Type 2 Diabetes (T2D) after Efsubaglutide Alfa TreatmentTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunPost Hoc Analysis of Efsubaglutide Alfa Monotherapy and Combined Therapy with Metformin in T2D Patients by Baseline CharacteristicsTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunEfficacy and Safety of Efsubaglutide Alfa in Patients with Obesity or Overweight—A Phase 2 StudyTrial in peopleInterventionsPaper